A detailed history of High Vista Strategies LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, High Vista Strategies LLC holds 162,708 shares of DVAX stock, worth $2.09 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
162,708
Previous 156,161 4.19%
Holding current value
$2.09 Million
Previous $1.75 Million 3.37%
% of portfolio
0.71%
Previous 0.7%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.05 - $11.61 $65,797 - $76,010
6,547 Added 4.19%
162,708 $1.81 Million
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $303,177 - $346,951
23,161 Added 17.41%
156,161 $2.18 Million
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $1.68 Million - $1.99 Million
133,000 New
133,000 $1.96 Million
Q4 2020

Feb 16, 2021

SELL
$3.73 - $5.6 $54,831 - $82,320
-14,700 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.32 - $11.7 $63,504 - $171,990
14,700 New
14,700 $64,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.